Clinical study of autologous noncultured epidermal cell transplantation for leucodelma treatment

Tanemura Atsushi0 个研究点目标入组 5 人开始时间: 2020年3月30日最近更新: 2023年10月17日

试验速览

(See the Outcome measures.)

•Men and women aged over 20 years old with a diagonosis of stable vitiligo who visited the department of dermatology Osaka University Hospital and who signed a written informed consent by themselves after receiving the explanation of clinical study.

•Apparently unstable patients defined as new areas of depigmentation or enlarging areas of depigmentation within the last 12 months.
•Patients with treatment of steroid, active vitamin D3, calcineurin inhibitor and light radiation therapy within the 4 weeks befor registration.
•History of hypertrophic scar, keloid scars or presence of Koebner's phenomenon
•Patients with allergies to antibiotics and local anaesthetics
•Patients with tape rash
•Pregnant women, lactating women and patients who deaire pregnancy during clinical studies.
•Positive serology of Hepatitis B and C, HIV, HTLV-1
•Patients who are participating in other clinical studies including interventions or non-interventions such as observation studies.
•Investigators judge the patiens should not paticipate in the study for any reason

发起方

Tanemura Atsushi